BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10379463)

  • 1. Pathogenesis of non-steroidal anti-inflammatory drug gastropathy.
    Fiorucci S; Antonelli E; Morelli O; Morelli A
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S6-13. PubMed ID: 10379463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological approach to the prevention of non-steroidal anti-inflammatory drug-induced gastropathy.
    Whittle BJ
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S43-7. PubMed ID: 10379469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon.
    Fiorucci S; Santucci L; Distrutti E
    Dig Liver Dis; 2007 Dec; 39(12):1043-51. PubMed ID: 17997373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs.
    Fiorucci S; Antonelli E; Distrutti E; Rizzo G; Mencarelli A; Orlandi S; Zanardo R; Renga B; Di Sante M; Morelli A; Cirino G; Wallace JL
    Gastroenterology; 2005 Oct; 129(4):1210-24. PubMed ID: 16230075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of NSAID-induced gastroduodenal mucosal injury.
    Wallace JL
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):691-703. PubMed ID: 11566035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins.
    Brzozowski T; Konturek PC; Pajdo R; Ptak-Belowska A; Kwiecien S; Pawlik M; Drozdowicz D; Sliwowski Z; Brzozowski B; Konturek SJ; Pawlik WW
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():89-102. PubMed ID: 18812631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal toxicity. Role of prostaglandins and leukotrienes.
    Peskar BM; Kleine A; Pyras F; Müller MK
    Med Toxicol; 1986; 1 Suppl 1():39-43. PubMed ID: 3547000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of non-steroidal anti-inflammatory drug-gastropathy.
    Fiorucci S; Antonelli E; Morelli A
    Dig Liver Dis; 2001 Dec; 33 Suppl 2():S35-43. PubMed ID: 11827361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself?
    Wallace JL
    Physiol Rev; 2008 Oct; 88(4):1547-65. PubMed ID: 18923189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
    Scarpignato C; Pelosini I
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S63-72. PubMed ID: 10379472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of prostaglandins in the pathogenesis of stomach ulcer and gastropathy caused by non-steroid anti-inflammatory drugs].
    Lazebnik LB; Tkachenko VN; Kolomiets EV
    Eksp Klin Gastroenterol; 2005; (1):4-7, 106. PubMed ID: 15991845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric mucosal damage by nonsteroidal anti-inflammatory drugs.
    Bennett A
    Int J Tissue React; 1989; 11(2):53-7. PubMed ID: 2693388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
    Lazzaroni M; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S73-8. PubMed ID: 10379473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinical approach to management of patients with non-steroidal anti-inflammatory gastropathy.
    Yeomans ND
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S89-92. PubMed ID: 10379475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric mucosal defense and cytoprotection: bench to bedside.
    Laine L; Takeuchi K; Tarnawski A
    Gastroenterology; 2008 Jul; 135(1):41-60. PubMed ID: 18549814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol.
    Koch M
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S54-62. PubMed ID: 10379471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
    Rainsford KD; Stetsko PI; Sirko SP; Debski S
    J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandins, NSAIDs, and cytoprotection.
    Wallace JL
    Gastroenterol Clin North Am; 1992 Sep; 21(3):631-41. PubMed ID: 1516961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal mucosal damage caused by non-steroidal anti-inflammatory drugs: role of bile salts.
    Petruzzelli M; Vacca M; Moschetta A; Cinzia Sasso R; Palasciano G; van Erpecum KJ; Portincasa P
    Clin Biochem; 2007 May; 40(8):503-10. PubMed ID: 17321514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prophylaxis and therapy of gastropathy caused by non-steroidal anti-inflammatory drugs].
    László A
    Orv Hetil; 2002 Jul; 143(27):1643-8. PubMed ID: 12180001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.